The cost of whole genome sequencing has plummeted to under $200 per sample (1), yet 73% of healthcare organizations report that genomic insights remain siloed and inaccessible at the point of care (2). The contrarian reality: the bottleneck in precision medicine is no longer data generation, but data infrastructure, interoperability, and clinical workflow integration (3).
Leading healthcare systems are discovering that successful genomic medicine programs require synchronized investments across three domains: computational infrastructure capable of real-time variant interpretation, EMR integration that surfaces actionable insights during clinical encounters, and automated compliance frameworks ensuring HIPAA and GDPR adherence across multi-jurisdictional patient cohorts (4).
